Stephanie Rhodebeck
Nurse Practitioner · Dublin, OHNPI 1295031458
Payments from drug & device makers
Across 200 payments — averaging $14.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$871
- AbbVie$657
- Johnson & Johnson$335
- E.r. Squibb & Sons, L.L.C.$321
- Sun Pharmaceutical Industries Inc.$156
- Regeneron Healthcare Solutions, Inc.$104
- plus $381 from 10 others
What the payments were for
- Food & beverage$2,55190%
- Education$27410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 62 | $871 |
| AbbVie | 71 | $657 |
| Johnson & Johnson | 14 | $335 |
| E.r. Squibb & Sons, L.L.C. | 19 | $321 |
| Sun Pharmaceutical Industries Inc. | 5 | $156 |
| Regeneron Healthcare Solutions, Inc. | 7 | $104 |
| Lilly USA, LLC | 4 | $79 |
| Sanofi | 5 | $78 |
| LEO Pharma Inc. | 4 | $75 |
| Novartis | 3 | $38 |
| Galderma Laboratories, L.p. | 1 | $35 |
| Organogenesis Inc. | 1 | $22 |
| Pfizer | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Organon | 1 | $8 |
How this compares
$2,824 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $227,070 |
| Fluorouracil | 102 | $6,928 |
| Clobetasol Propionate | 64 | $3,395 |
| Triamcinolone Acetonide | 89 | $1,025 |
| Ketoconazole | 74 | $872 |
| Clindamycin Phosphate | 16 | $662 |
| Econazole Nitrate | 15 | $642 |
| Doxycycline Hyclate | 26 | $554 |
| Ciclopirox | 25 | $468 |
| Ammonium Lactate | 11 | $327 |
| Mupirocin | 27 | $167 |
| ValacyclovirValacyclovir Hcl | 11 | $146 |
| Terbinafine Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Dublin
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.